Chromatin-immune connections: Regulation of MHC and other genes

Journal of Reproductive Immunology

Volumn 48, Issue 1, 2000, Pages 1-15

  Magner, William J ^a   Tomasi, Thomas B ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

Chromatin regulation; Gene; MHC

Indexed keywords

ADENOSINE TRIPHOSPHATE; HISTONE; REPRESSOR PROTEIN; TRANSCRIPTION FACTOR;

ACETYLATION; CHROMATIN; CHROMATIN STRUCTURE; CPG ISLAND; DNA METHYLATION; GENE EXPRESSION REGULATION; HISTOCOMPATIBILITY GENE; HUMAN; HYDROLYSIS; IMMUNOREGULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; REVIEW; TRANSCRIPTION REGULATION;

EID: 0033825901     PISSN: 01650378     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0378(00)00066-8     Document Type: Article

References (62)

1. Abbas A.K. Die and let live: eliminating dangerous lymphocytes. Cell. 84:1996;655-657.
2. Agarwal S., Rao A. Modulation of chromatin structure regulates cytokine gene expression during T-cell differentiation. Immunity. 9:1998;765-775.
3. Avril T., Jarousseau A.C., Watier H., Boucraut J., Le Bouteiller P., Bardos P., Thibault G. Trophoblast cell line resistance to NK lysis mainly involves an HLA class I-independent mechanism. J. Immunol. 162:1999;5902-5909.
4. Benoist C., Mathis D. Autoimmunity. The pathogen connection. Nature. 394:1998;227-228.
5. Blanch V.J., Piskurich J.F., Kaetzel C.S. Coordinate regulation of IFN regulatory factor-1 and the polymeric Ig receptor by proinflammatory cytokines. J. Immunol. 162:1999;1232-1235.
6. Cairns B.R., Lorch Y., Li Y., Zhang M., Lacomis L., Erdjument-Bromage H., Tempst P., Du J., Laurent B., Kornberg R.D. RSC, an essential, abundant chromatin-remodeling complex. Cell. 87:1996;1249-1260.
7. Collinge M., Pardi R., Bender J.R. Class II transactivator-independent endothelial cell MHC class II gene activation induced by lymphocyte adhesion. J. Immunol. 161:1998;1589-1593.
8. Croy B.A., Kiso Y. Granulated metrial gland cells: a natural killer cell subset of the pregnant murine uterus. Microsc. Res. Tech. 25:1993;189-200.
9. Drake B.L., Head J.R. Murine trophoblast can be killed by lymphokine-activated killer cells. J. Immunol. 143:1989;9-14.
10. Drake B.L., Head J.R. Murine trophoblast cells are not killed by tumor necrosis factor-α J. Reprod. Immunol. 17:1990;93-99.
11. French L.E., Tschopp J. Inhibition of death receptor signaling by FLICE-inhibitory protein as a mechanism for immune escape of tumors. J. Exp. Med. 190:1999;891-894.
12. Glick R.D., Swendeman S.L., Coffey D.C., Rifkind R.A., Marks P.A., Richon V.M., La Quaglia M.P. Hybrid polar histone deacetylase inhibitor induces apoptosis and CD95/CD95 ligand expression in human neuroblastoma. Cancer Res. 59:1999;4392-4399.
13. Glimcher L.H., Kara C.J. Sequences and factors: a guide to MHC class-II transcription. Annu. Rev. Immunol. 10:1992;13-49.
14. Gobin S.J.P., Peijnenburg A., Keijsers V., van den Elsen P.J. Site α is crucial for two routes of IFN-γ-induced MHC class I transactivation: the ISRE-mediated route and a novel pathway involving CIITA. Immunity. 6:1997;601-611.
15. Gourley T., Roys S., Lukacs N.W., Kunkel S.L., Flavell R.A., Chang C.H. A novel role for the major histocompatibility complex class II transactivator CIITA in the repression of IL-4 production. Immunity. 10:1999;377-386.
16. Grunstein M. Histone acetylation in chromatin structure and transcription. Nature. 389:1997;349-352.
17. Gu W., Roeder R.G. Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell. 90:1997;595-606.
18. Hague A., Manning A.M., Hanlon K.A., Huschtscha L.I., Hart D., Paraskeva C. Sodium butyrate induces apoptosis in human colonic tumour cell lines in a p53-independent pathway: implications for the possible role of dietary fibre in the prevention of large-bowel cancer. Int. J. Cancer. 55:1993;498-505.
19. Howcroft T.K., Murphy C., Weissman J.D., Huber S.J., Sawadogo M., Singer D.S. Upstream stimulatory factor regulates major histocompatibility complex class I gene expression: the U2δE4 splice variant abrogates E-box activity. Mol. Cell. Biol. 19:1999;4788-4797.
20. Hunt J.S., Vassmer D., Ferguson T.A., Miller L. Fas ligand is positioned in mouse uterus and placenta to prevent trafficking of activated leukocytes between the mother and the conceptus. J. Immunol. 158:1997;4122-4128.
21. Kwon H.J., Owa T., Hassig C.A., Shimada J., Schreiber S.L. Depudecin induces morphological reversion of transformed fibroblasts via the inhibition of histone deacetylase. Proc. Natl. Acad. Sci. USA. 95:1998;3356-3361.
22. Lee Y.J., Han Y., Lu H.T., Nguyen V., Qin H., Howe P.H., Hocevar B.A., Boss J.M., Ransohoff R.M., Benveniste E.N. TGF-β suppresses IFN-γ induction of class II MHC gene expression by inhibiting class II transactivator messenger RNA expression. J. Immunol. 158:1997;2065-2075.
23. Letterio J.J., Geiser A.G., Kulkarni A.B., Dang H., Kong L., Nakabayashi T., Mackall C.L., Gress R.E., Roberts A.B. Autoimmunity associated with TGF-β1-deficiency in mice is dependent on MHC class II antigen expression. J. Clin. Invest. 98:1996;2109-2119.
24. Ljunggren G., Anderson D.J. Cytokine induced modulation of MHC class I and class II molecules on human cervical epithelial cells. J. Reprod. Immunol. 38:1998;123-138.
25. Mach B., Steimle V., Martinez-Soria E., Reith W. Regulation of MHC class II: lessons from a disease. Annu. Rev. Immunol. 14:1996;301-331.
26. Magner, W., Kazim, A.L., Stewart, C., Catalano, G., Grande, C., Keiser, N., Maier, P.G., Romano, M., Tomasi, T.B., 2000. Induction of MHC and CD40 gene expression by histone deacetlyane inhibitors (submitted for publication).
27. Martin B.K., Chin K.C., Olsen J.C., Skinner C.A., Dey A., Ozato K., Ting J.P. Induction of MHC class I expression by the MHC class II transactivator CIITA. Immunity. 6:1997;591-600.
28. Mayer L., Shlien R. Evidence for function of Ia molecules on gut epithelial cells in man. J. Exp. Med. 166:1987;1471-1483.
29. Medawar P.B. Some immunological and endocrinological problems raised by the evolution viviparity in vertebrates. Symp. Soc. Exp. Biol. 7:1953;320.
30. Medina, V., Edmund, B., Young, GH.P., James, R., Appleton, S., Zalewski, P.D., 1997. Induction of caspase-3 protease activity and apopotsis by bytyrate and frichostatin A (inhibitor of histonedeacety(ase): dependance on protein synthesis and synergy with a mitrochondrica/cytochrome C-dependant pathway. Cancer Res. 57, 3697-3707.
31. Miller D.M., Rahill B.M., Boss J.M., Lairmore M.D., Durbin J.E., Waldman J.W., Sedmak D.D. Human cytomegalovirus inhibits major histocompatibility complex class II expression by disruption of the Jak/Stat pathway. J. Exp. Med. 187:1998;675-683.
32. Molina C.A., Foulkes N.S., Lalli E., Sassone-Corsi P. Inducibility and negative autoregulation of CREM: an alternative promoter directs the expression of ICER, an early response repressor. Cell. 75:1993;875-886.
33. Moreno C.S., Beresford G.W., Louis-Plence P., Morris A.C., Boss J.M. CREB regulates MHC class II expression in a CIITA-dependent manner. Immunity. 10:1999;143-151.
34. Morris A.C., Riley J.L., Fleming W.H., Boss J.M. MHC class II gene silencing in trophoblast cells is caused by inhibition of CIITA expression. Am. J. Reprod. Immunol. 40:1998;385-394.
35. Muhlethaler-Mottet A., Otten L.A., Steimle V., Mach B. Expression of MHC class II molecules in different cellular and functional compartments is controlled by differential usage of multiple promoters of the transactivator CIITA. EMBO J. 16:1997;2851-2860.
36. Murphy S.P., Tomasi T.B. Absence of MHC class II antigen expression in trophoblast cells results from a lack of class II transactivator (CIITA) gene expression. Mol. Reprod. Dev. 51:1998;1-12.
37. Nandan D., Reiner N.E. TGF-β attenuates class II transactivator and reveals an accessory pathway of IFN-γ action. J. Immunol. 158:1997;1095-1101.
38. Ng H.H., Zhang Y., Hendrich B., Johnson C.A., Turner B.M., Erdjument-Bromage H., Tempst P., Reinberg D., Bird A. MBD2 is a transcriptional repressor belonging to the MeCP1 histone deacetylase complex. Nat. Genet. 23:1999;58-61.
39. Pazin M.J., Kadonaga J.T. What's up and down with histone deacetylation and transcription? Cell. 89:1997;325-328.
40. Phillips T.A., Ni J., Pan G., Ruben S.M., Wei Y.F., Pace J.L., Hunt J.S. TRAIL (Apo-2L) and TRAIL receptors in human placentas: implications for immune privilege. J. Immunol. 162:1999;6053-6059.
41. Riley J.L., Westerheide S.D., Price J.A., Brown J.A., Boss J.M. Activation of class II MHC genes requires both the X box region and the class II transactivator (CIITA). Immunity. 2:1995;533-543.
42. Saunders N., Dicker A., Popa C., Jones S., Dahler A. Histone deacetylase inhibitors as potential anti-skin cancer agents. Cancer Res. 59:1999;399-404.
43. Silacci P., Mottet A., Steimle V., Reith W., Mach B. Developmental extinction of major histocompatibility complex class II gene expression in plasmocytes is mediated by silencing of the transactivator gene CIITA. J. Exp. Med. 180:1994;1329-1336.
44. Streilein J.W. Unraveling immune privilege. Science. 270:1995;1158-1159.
45. Struhl K. Histone acetylation and transcriptional regulatory mechanisms. Genes Dev. 12:1998;599-606.
46. Tsuji N., Kobayashi M., Nagashima K., Wakisaka Y., Koizumi K. A new antifungal antibiotic, trichostatin. J. Antibiot. 29:1976;1-6.
47. Tsukiyama T., Wu C. Chromatin remodeling and transcription. Curr. Opin. Genet. Dev. 7:1997;182-191.
48. Van Lint C., Emiliani S., Verdin E. The expression of a small fraction of cellular genes is changed in response to histone hyperacetylation. Gene Exp. 5:1996;245-253.
49. Wade P., Wolffe S.P. Histone acetyltransferases in control. Curr. Biol. 7:1997;R82-R84.
50. Wade P.A., Gegonne A., Jones P.L., Ballestar E., Aubry F., Wolffe A.P. Mi-2 complex couples DNA methylation to chromatin remodelling and histone deacetylation. Nat. Genet. 23:1999;62-66.
51. Walker P.R., Saas P., Dietrich P.Y. Role of Fas ligand (CD95L) in immune escape: the tumor cell strikes back. J. Immunol. 158:1997;4521-4524.
52. Wang W., Xue Y., Zhou S., Kuo A., Cairns B.R., Crabtree G.R. Diversity and specialization of mammalian SWI/SNF complexes. Genes Dev. 10:1996;2117-2130.
53. Wegmann T.G., Lin H., Guilbert L., Mosmann T.R. Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon? Immunol. Today. 14:1993;353-356.
54. Williams G.S., Mallin M., Vremec D., Chang C.H., Boyd R., Benoist C., Mathis D. Mice lacking the transcription factor CIITA - a second look. Int. Immunol. 10:1998;1957-1967.
55. Wira C.R. Role of sex hormones and cytokines in regulating the mucosal immune system in the female reproductive tract. Ogra P.L., Mestecky J., Lamm M.E., Strober W., McGhee J.R., Bienenstock J. Handbook of Mucosal Diseases. 1999;1449-1461 Academic Press, New York. (Chapter 92).
56. Wolffe A.P. Transcriptional control. Sinful repression. Nature. 387:1997;16-17.
57. Wolffe A.P. Epigenetics: regulation through repression. Science. 286:1999;481-486.
58. Workman J.L., Kingston R.E. Alteration of nucleosome structure as a mechanism of transcriptional regulation. Annu. Rev. Biochem. 67:1998;545-579.
59. Wotton D., Lo R.S., Lee S., Massague J. A Smad transcriptional corepressor. Cell. 97:1999;29-39.
60. Zhong G., Fan T., Liu L. Chlamydia inhibits interferon gamma-inducible major histocompatibility complex class II expression by degradation of upstream stimulatory factor 1. J. Exp. Med. 189:1999;1931-1938.
61. Zhou H., Su H.S., Zhang X., Douhan J. III, Glimcher L.H. CIITA-dependent and -independent class II MHC expression revealed by a dominant negative mutant. J. Immunol. 158:1997;4741-4749.
62. Zuckermann F.A., Head J.R. Murine trophoblast resists cell-mediated lysis. Resistance to allospecific cytotoxic T lymphocytes. J. Immunol. 139:1987;2856-2864.